Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
XIST
Specific or universal ncRNAs
Universal ncRNAs
Class
Long non-coding RNA
Biomarker
Yes
Biomarker application
Diagnosis/Prognosis
Upstream regulatory factor
Not available
Downstream target
Not available
Differential expression in
recurrence vs. nonrecurrence
Up
Cancer name
Triple-Negative Breast Cancer
Alias
Breast Cancer
Cancer site
Breast
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Down
ncRNA differential expression in
cancer
patients vs. health people
Up
Number of patients
91
Male patients
Not available
Female patients
Not available
Age range and number
40(<=53)+51(>53)
Recurrence patients
25
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
Levels of serum exo-XIST may serve as a diagnostic and prognostic biomarker to predict the recurrent TNBC-loading status
Tissue resource
blood serum samples were collected from patients with histologically proven triple-negative breast cancer after operation
Experiment
qRT-PCR,Western blot
Institute
Country
Continent
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.